Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'

According to a new market report published by Lucintel, the future of the cell delivery market looks promising with opportunities in musculoskeletal, dermatology, cardiology, and drug discovery & development applications. The global cell delivery market is expected to grow with a CAGR of 7% from 2020 to 2025. The major drivers for this market are surge in demand for regenerative medicines, rising drug development activity, and increasing prevalence of cancer.


 


To download report brochure, please go to https://www.lucintel.com/cell-delivery-market.aspx and click "download brochure" tab from the menu


 

Cell delivery comprises of two methods having two purposes, first is to precisely deliver cellular therapeutics to a target site and the second is to ensure that the delivered cell therapeutics work.

Within this market, hospitals & specialty clinics will remain the largest end user segment over the forecast period due to increasing cases of cancer and rising prevalance of musculoskeletal disorders.

North America will remain the largest region over the forecast period due to increasing prevalance of cancer, rising research activities related to drug discovery, and presence of advanced healthcare infrastructure in the region.

Medipost, Pharmicell, and Mesoblast are among the major suppliers in the global cell delivery market.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global cell delivery market by treatment, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Cell Delivery Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global cell delivery market by treatment, application, end user, and region as follows:

By Treatment [Value ($ Million) shipment analysis for 2014 – 2025]:



  • Allogeneic


  • Autologous


By Application [Value ($ Million) shipment analysis for 2014 – 2025]:



  • Musculoskeletal


  • Dermatology


  • Cardiology


  • Drug Discovery & Development


  • Other Applications


By End User [Value ($ Million) shipment analysis for 2014 – 2025]:



  • Academic & Research Institutes


  • Hospitals & Specialty Clinics


By Region [Value ($ Million) shipment analysis for 2014 – 2025]:



  • North America




  • United States


  • Canada


  • Mexico




  • Europe




  • United Kingdom


  • Germany


  • France




  • Asia Pacific




  • China


  • India


  • Japan




  • The Rest of the World




  • Brazil


 

This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.